{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:59:16Z","timestamp":1760101156765,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3C7A1043848","2017R1D1A1B03028797"],"award-info":[{"award-number":["2017M3C7A1043848","2017R1D1A1B03028797"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with Parkinson\u2019s disease (PD) oftentimes develop olfactory dysfunction in their early stages, converting the nasal environment into a useful source of potential biomarkers. Here we determined the possible application of nasal fluid cells for PD biomarker identification. Thirty PD patients and 13 age-matched healthy controls were enrolled in this study. Messenger RNA levels of selected PD-related genes were monitored through real-time quantitative PCR. Target gene transcripts can be efficiently amplified from the cDNA library from human nasal fluid cell pellets. And subsequent analysis showed both a marked downregulation of parkin transcripts and an upregulation of AIMP2 in PD patients when compared to controls (cutoff value\u2009=\u20091.753 for with 84.2% sensitivity and 84.6% specificity; 0.359 for parkin with 76.7% sensitivity and 76.9 specificity). Moreover, alteration pattern of parkin and AIMP2 in PD was distinct from another neurodegenerative disease, multiple system atrophy. Analysis in both the early and late stages of PD cases reported that parkin levels inversely correlated with PD stages. Our results validate the practical value of easily accessible nasal fluid cells and the utility of both AIMP2 and parkin as potential biomarkers for PD diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-019-47579-6","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T10:02:57Z","timestamp":1564567377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quantitative analysis of nasal transcripts reveals potential biomarkers for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Hyojung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-4629","authenticated-orcid":false,"given":"Seok-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Mi","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Song","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-2279","authenticated-orcid":false,"given":"Yunjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-5894","authenticated-orcid":false,"given":"Seok-Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"47579_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang, A. E. & Lozano, A. M. Parkinson\u2019s disease. First of two parts. N Engl J Med 339, 1044\u20131053, https:\/\/doi.org\/10.1056\/NEJM199810083391506 (1998).","journal-title":"N Engl J Med"},{"key":"47579_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","volume":"8","author":"RL Doty","year":"2012","unstructured":"Doty, R. L. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8, 329\u2013339, https:\/\/doi.org\/10.1038\/nrneurol.2012.80 (2012).","journal-title":"Nat Rev Neurol"},{"key":"47579_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","volume":"62","author":"CH Hawkes","year":"1997","unstructured":"Hawkes, C. H., Shephard, B. C. & Daniel, S. E. Olfactory dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62, 436\u2013446 (1997).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"47579_CR4","doi-asserted-by":"publisher","first-page":"e0149286","DOI":"10.1371\/journal.pone.0149286","volume":"11","author":"J Li","year":"2016","unstructured":"Li, J. et al. Changes in Olfactory Bulb Volume in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. PLoS One 11, e0149286, https:\/\/doi.org\/10.1371\/journal.pone.0149286 (2016).","journal-title":"PLoS One"},{"key":"47579_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2222.2005.02206.x","volume":"35","author":"M Benson","year":"2005","unstructured":"Benson, M. et al. Gene profiling reveals decreased expression of uteroglobin and other anti-inflammatory genes in nasal fluid cells from patients with intermittent allergic rhinitis. Clin Exp Allergy 35, 473\u2013478, https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02206.x (2005).","journal-title":"Clin Exp Allergy"},{"key":"47579_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7961-10-4","volume":"10","author":"K Irander","year":"2012","unstructured":"Irander, K., Palm, J. P., Borres, M. P. & Ghafouri, B. Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis. Clin Mol Allergy 10, 4, https:\/\/doi.org\/10.1186\/1476-7961-10-4 (2012).","journal-title":"Clin Mol Allergy"},{"key":"47579_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep20364","volume":"6","author":"J Moon","year":"2016","unstructured":"Moon, J. et al. Early diagnosis of Alzheimer\u2019s disease from elevated olfactory mucosal miR-206 level. Sci Rep 6, 20364, https:\/\/doi.org\/10.1038\/srep20364 (2016).","journal-title":"Sci Rep"},{"key":"47579_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1569-1993(02)00072-3","volume":"1","author":"C Bergoin","year":"2002","unstructured":"Bergoin, C. et al. Cell and cytokine profile in nasal secretions in cystic fibrosis. J Cyst Fibros 1, 110\u2013115 (2002).","journal-title":"J Cyst Fibros"},{"key":"47579_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2223\/JPED.234","volume":"77","author":"LC Kovalhuk","year":"2001","unstructured":"Kovalhuk, L. C., Rosario, N. A. & Carvalho, A. [Inflammatory mediators, cell counts in nasal lavage and computed tomography of the paranasal sinuses in atopic children]. J Pediatr (Rio J) 77, 271\u2013278 (2001).","journal-title":"J Pediatr (Rio J)"},{"key":"47579_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore, D. J., West, A. B., Dawson, V. L. & Dawson, T. M. Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci 28, 57\u201387, https:\/\/doi.org\/10.1146\/annurev.neuro.28.061604.135718 (2005).","journal-title":"Annu Rev Neurosci"},{"key":"47579_CR11","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/hmg\/ddg159","volume":"12","author":"O Corti","year":"2003","unstructured":"Corti, O. et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 12, 1427\u20131437 (2003).","journal-title":"Hum Mol Genet"},{"issue":"Suppl 1","key":"47579_CR12","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/mds.22798","volume":"25","author":"TM Dawson","year":"2010","unstructured":"Dawson, T. M. & Dawson, V. L. The role of parkin in familial and sporadic Parkinson\u2019s disease. Mov Disord 25(Suppl 1), S32\u201339, https:\/\/doi.org\/10.1002\/mds.22798 (2010).","journal-title":"Mov Disord"},{"key":"47579_CR13","doi-asserted-by":"publisher","first-page":"16691","DOI":"10.1073\/pnas.1006083107","volume":"107","author":"HS Ko","year":"2010","unstructured":"Ko, H. S. et al. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin\u2019s ubiquitination and protective function. Proc Natl Acad Sci USA 107, 16691\u201316696, https:\/\/doi.org\/10.1073\/pnas.1006083107 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"47579_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin, J. H. et al. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144, 689\u2013702, https:\/\/doi.org\/10.1016\/j.cell.2011.02.010 (2011).","journal-title":"Cell"},{"key":"47579_CR15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.3500","volume":"16","author":"Y Lee","year":"2013","unstructured":"Lee, Y. et al. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci 16, 1392\u20131400, https:\/\/doi.org\/10.1038\/nn.3500 (2013).","journal-title":"Nat Neurosci"},{"key":"47579_CR16","doi-asserted-by":"publisher","first-page":"106721","DOI":"10.18632\/oncotarget.21828","volume":"8","author":"H Kim","year":"2017","unstructured":"Kim, H. et al. Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson\u2019s disease models. Oncotarget 8, 106721\u2013106739, https:\/\/doi.org\/10.18632\/oncotarget.21828 (2017).","journal-title":"Oncotarget"},{"key":"47579_CR17","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","volume":"23","author":"AL Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier, A. L. et al. c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson\u2019s disease. Hum Mol Genet 23, 2858\u20132879, https:\/\/doi.org\/10.1093\/hmg\/ddt674 (2014).","journal-title":"Hum Mol Genet"},{"key":"47579_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JPD-160867","volume":"6","author":"F Pagan","year":"2016","unstructured":"Pagan, F. et al. Nilotinib Effects in Parkinson\u2019s disease and Dementia with Lewy bodies. J Parkinsons Dis 6, 503\u2013517, https:\/\/doi.org\/10.3233\/JPD-160867 (2016).","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"47579_CR19","doi-asserted-by":"publisher","first-page":"10.1.1-10.1.14","DOI":"10.1002\/0471142301.ns1001s49","volume":"49","author":"Joel S. Perlmutter","year":"2009","unstructured":"Perlmutter, J. S. Assessment of Parkinson disease manifestations. Curr Protoc Neurosci Chapter 10, Unit10 11, https:\/\/doi.org\/10.1002\/0471142301.ns1001s49 (2009).","journal-title":"Current Protocols in Neuroscience"},{"key":"47579_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408, https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"47579_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.anai.2017.01.018","volume":"118","author":"P Badorrek","year":"2017","unstructured":"Badorrek, P., Muller, M., Koch, W., Hohlfeld, J. M. & Krug, N. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure. Ann Allergy Asthma Immunol 118, 290\u2013297, https:\/\/doi.org\/10.1016\/j.anai.2017.01.018 (2017).","journal-title":"Ann Allergy Asthma Immunol"},{"key":"47579_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"GK Wenning","year":"1997","unstructured":"Wenning, G. K., Tison, F., Ben Shlomo, Y., Daniel, S. E. & Quinn, N. P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12, 133\u2013147, https:\/\/doi.org\/10.1002\/mds.870120203 (1997).","journal-title":"Mov Disord"},{"key":"47579_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/cdd.2010.142","volume":"18","author":"L Bouman","year":"2011","unstructured":"Bouman, L. et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 18, 769\u2013782, https:\/\/doi.org\/10.1038\/cdd.2010.142 (2011).","journal-title":"Cell Death Differ"},{"key":"47579_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00614-w","volume":"7","author":"S Ham","year":"2017","unstructured":"Ham, S. et al. Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson\u2019s disease model. Sci Rep 7, 525, https:\/\/doi.org\/10.1038\/s41598-017-00614-w (2017).","journal-title":"Sci Rep"},{"key":"47579_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/00207454.2011.580866","volume":"121","author":"M Cai","year":"2011","unstructured":"Cai, M., Tian, J., Zhao, G. H., Luo, W. & Zhang, B. R. Study of methylation levels of parkin gene promoter in Parkinson\u2019s disease patients. Int J Neurosci 121, 497\u2013502, https:\/\/doi.org\/10.3109\/00207454.2011.580866 (2011).","journal-title":"Int J Neurosci"},{"key":"47579_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1523\/JNEUROSCI.1833-10.2011","volume":"31","author":"SZ Imam","year":"2011","unstructured":"Imam, S. Z. et al. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson\u2019s disease. J Neurosci 31, 157\u2013163, https:\/\/doi.org\/10.1523\/JNEUROSCI.1833-10.2011 (2011).","journal-title":"J Neurosci"},{"key":"47579_CR27","doi-asserted-by":"publisher","first-page":"7968","DOI":"10.1523\/JNEUROSCI.2172-05.2005","volume":"25","author":"HS Ko","year":"2005","unstructured":"Ko, H. S. et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38\/JTV-1, leads to catecholaminergic cell death. J Neurosci 25, 7968\u20137978, https:\/\/doi.org\/10.1523\/JNEUROSCI.2172-05.2005 (2005).","journal-title":"J Neurosci"},{"key":"47579_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28986-7","volume":"8","author":"JCM Schlachetzki","year":"2018","unstructured":"Schlachetzki, J. C. M. et al. A monocyte gene expression signature in the early clinical course of Parkinson\u2019s disease. Sci Rep 8, 10757, https:\/\/doi.org\/10.1038\/s41598-018-28986-7 (2018).","journal-title":"Sci Rep"},{"key":"47579_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55, 181\u2013184 (1992).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"47579_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman, S. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670\u2013676, https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15 (2008).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47579-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:07:58Z","timestamp":1671278878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47579-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47579"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47579-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"8 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11111"}}